Innovation for improving patient outcomes - Focus on healing, short DAPT and risk reduction
Sponsored by Boston Scientific
Consult this session on innovation for improving patient outcomes, while focussing on healing, short DAPT for elderly patients and risk reduction whilst looking at data from Watchman LAAC in Asian environments. Why does the customized design of Synergy bioabsorbable-polymer stent give better healing and increased treatment options for complex lesions?
- To learn more about why stent platform matters
- To learn more about Synergy stent's performance in patients over 75-year old with a shortened DAPT regime, in a randomised clinical trial setting vs. BMS
- To learn more about the real world data of Watchman in Asian population